RNA therapies for CNS diseases DOI
Valentina Di Francesco, Andy Jian Kai Chua, Di Huang

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2024, Номер 208, С. 115283 - 115283

Опубликована: Март 16, 2024

Язык: Английский

Nanotechnology and bioengineering approaches to improve the potency of mesenchymal stem cell as an off‐the‐shelf versatile tumor delivery vehicle DOI

Mojtaba Taheri,

Hossein Abdul Tehrani, Sadegh Dehghani

и другие.

Medicinal Research Reviews, Год журнала: 2024, Номер 44(4), С. 1596 - 1661

Опубликована: Фев. 1, 2024

Abstract Targeting actionable mutations in oncogene‐driven cancers and the evolution of immuno‐oncology are two prominent revolutions that have influenced cancer treatment paradigms caused emergence precision oncology. However, intertumoral intratumoral heterogeneity main challenges both fields treatment. In other words, finding a universal marker or pathway patients suffering from particular type is challenging. Therefore, targeting single hallmark with targeted therapeutic will not be efficient for fighting against tumor heterogeneity. Mesenchymal stem cells (MSCs) possess favorable characteristics cellular therapy, including their hypoimmune nature, inherent tumor‐tropism property, straightforward isolation, multilineage differentiation potential. MSCs can loaded various chemotherapeutics oncolytic viruses. The combination these intrinsic features possibility genetic manipulation makes them versatile delivery vehicle used vivo selective chemotherapeutic biological therapeutics. as biofactory local production chemical anticancer agents at site. MSC‐mediated immunotherapy could facilitate sustained release immunotherapeutic specifically site, allow achievement concentrations without need repetitive systemic administration high doses. Despite enthusiasm evoked by preclinical studies MSC therapy approaches, translation into clinical applications has faced serious challenges. This manuscript, critical viewpoint, reviewed evaluated tool gene immunotherapy, chemotherapy. Then, novel nanotechnology bioengineering approaches improve potency overcoming related to low localization sites discussed.

Язык: Английский

Процитировано

11

CRISPR–Cas9 delivery strategies for the modulation of immune and non-immune cells DOI
Shahad K. Alsaiari, Behnaz Eshaghi, Bujie Du

и другие.

Nature Reviews Materials, Год журнала: 2024, Номер unknown

Опубликована: Окт. 16, 2024

Язык: Английский

Процитировано

8

In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications DOI
Kun Huang,

Daniel Zapata,

Yan Tang

и другие.

Biomaterials, Год журнала: 2022, Номер 291, С. 121876 - 121876

Опубликована: Окт. 28, 2022

Язык: Английский

Процитировано

33

Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy DOI Creative Commons
Ankit Kumar Dubey, Ebrahim Mostafavi

Frontiers in Chemistry, Год журнала: 2023, Номер 11

Опубликована: Сен. 28, 2023

The use of biomaterials in delivering CRISPR/Cas9 for gene therapy infectious diseases holds tremendous potential. This innovative approach combines the advantages with protective properties biomaterials, enabling accurate and efficient editing while enhancing safety. Biomaterials play a vital role shielding components, such as lipid nanoparticles or viral vectors, from immunological processes degradation, extending their effectiveness. By utilizing flexibility tailored systems can be designed to address specific genetic diseases, paving way personalized therapeutics. Furthermore, this delivery method offers promising avenues combating illnesses by precisely modifying pathogen genomes, reducing pathogenicity. facilitate site-specific modifications, ensuring effective infected cells minimizing off-target effects. However, challenges remain, including optimizing efficiency, effects, long-term safety, establishing scalable production techniques. Thorough research, pre-clinical investigations, rigorous safety evaluations are imperative successful translation laboratory clinical applications. In review, we discussed how using revolutionizes disease treatment, offering precise safe capabilities potential significantly improve human health quality life.

Язык: Английский

Процитировано

21

Viral Vectors, Exosomes, and Vexosomes: Potential armamentarium for delivering CRISPR/Cas to cancer cells DOI
Mahdieh Farzanehpour, Ali Miri, Akbar Ghorbani Alvanegh

и другие.

Biochemical Pharmacology, Год журнала: 2023, Номер 212, С. 115555 - 115555

Опубликована: Апрель 18, 2023

Язык: Английский

Процитировано

17

Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy DOI Creative Commons

Mihaela Kancheva,

Lauren I. Aronson,

Tara Pattilachan

и другие.

Journal of Functional Biomaterials, Год журнала: 2023, Номер 14(7), С. 373 - 373

Опубликована: Июль 17, 2023

Current radiologic and medication administration is systematic has widespread side effects; however, the of microbubbles nanobubbles (MNBs) possibility to provide therapeutic diagnostic information without same ramifications. Microbubbles (MBs), for instance, have been used ultrasound (US) imaging due their ability remain in vessels when exposed ultrasonic waves. On other hand, (NBs) can be further benefits, including chronic treatments osteoporosis cancer, gene delivery, treatment acute conditions, such as brain infections urinary tract (UTIs). Clinical trials are also being conducted different administrations utilizations MNBs. Overall, there large horizons benefits MNBs radiology, general medicine, surgery, many more medical applications. As such, this review aims evaluate most recent publications from 2016 2022 report current uses innovations

Язык: Английский

Процитировано

16

Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses DOI

Anyeseu Park,

Jeong Yoon Lee

The Journal of Microbiology, Год журнала: 2024, Номер 62(7), С. 491 - 509

Опубликована: Июль 1, 2024

Язык: Английский

Процитировано

7

Development of ionizable lipid nanoparticles and a lyophilized formulation for potent CRISPR-Cas9 delivery and genome editing DOI
Qian Sun, Hongqian Zhang, Feng Ding

и другие.

International Journal of Pharmaceutics, Год журнала: 2024, Номер 652, С. 123845 - 123845

Опубликована: Янв. 22, 2024

Язык: Английский

Процитировано

6

Split Proteins and Reassembly Modules for Biological Applications DOI Creative Commons
Jieun Bae, Jonghoon Kim, Jongdoo Choi

и другие.

ChemBioChem, Год журнала: 2024, Номер 25(10)

Опубликована: Март 26, 2024

Abstract Split systems, modular entities enabling controlled biological processes, have become instrumental in research. This review highlights their utility across applications like gene regulation, protein interaction identification, and biosensor development. Covering significant progress over the last decade, it revisits traditional split proteins such as GFP, luciferase, inteins, explores advancements technologies Cas base editors. We also examine reassembly modules diverse fields, from regulation to therapeutic innovation. offers a comprehensive perspective on recent evolution of systems

Язык: Английский

Процитировано

6

Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects DOI

Jeevitha Rajanathadurai,

Elumalai Perumal,

Jospin Sindya

и другие.

Functional & Integrative Genomics, Год журнала: 2024, Номер 24(5)

Опубликована: Сен. 18, 2024

Язык: Английский

Процитировано

6